Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
12,840,897
-
Share change
-
-1,129,283
-
Total reported value
-
$499,509,000
-
Put/Call ratio
-
148%
-
Price per share
-
$38.90
-
Number of holders
-
81
-
Value change
-
+$13,572,823
-
Number of buys
-
64
-
Number of sells
-
50
Institutional Holders of NEURODERM LTD - ORD SHS as of Q3 2017
As of 30 Sep 2017,
NEURODERM LTD - ORD SHS was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,840,897 shares.
The largest 10 holders included
CNH PARTNERS LLC, Sandell Asset Management Corp., OMNI PARTNERS LLP, JPMORGAN CHASE & CO, OxFORD Asset Management LLP, BAKER BROS. ADVISORS LP, Allianz Asset Management GmbH, City Financial Investment Co Ltd, WATER ISLAND CAPITAL LLC, and Vivaldi Asset Management, LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.